Characteristic |  | All (N = 158) | Responder (N = 90) | Non-responder (N = 68) | P-value |
---|---|---|---|---|---|
Patients with repeats, N | Â | 5 | 3 | 2 | Â |
Additional repeats, No | 7 | 4 | 3 | Â | |
Treatment, N. (%): | IPI + PD1c | 74 (46.8) | 47 (52.2) | 27 (39.7) | 0.1615a |
PD1c | 84 (53.2) | 43 (47.8) | 41 (60.3) | ||
Biopsy sites, N. (%): | Â | Â | Â | Â | 0.1461b |
 | Brain | 15 (9.5) | 9 (10) | 6 (8.8) | |
 | Liver | 2 (1.3) | 2 (2.2) |  | |
 | Lung | 7 (4.4) | 4 (4.4) | 3 (4.4) | |
 | Lymph node | 44 (27.8) | 21 (23.3) | 23 (33.8) | |
 | Mucosa | 2 (1.3) |  | 2 (2.9) | |
 | Primary | 6 (3.8) | 5 (5.6) | 1 (1.5) | |
 | Small bowel | 3 (1.9) | 2 (2.2) | 1 (1.5) | |
 | Subcutaneous | 73 (46.2) | 41 (45.6) | 32 (47.1) | |
 | Other | 6 (3.8) | 6 (6.7) |  |